GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Net Change in Cash

Jacobio Pharmaceuticals Group Co (HKSE:01167) Net Change in Cash : HK$221.1 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Jacobio Pharmaceuticals Group Co's Net Change in Cash for the six months ended in Dec. 2024 was HK$336.6 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was HK$221.1 Mil.

Jacobio Pharmaceuticals Group Co Net Change in Cash Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Net Change in Cash Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial 1,323.04 118.51 -1,008.20 -169.78 222.01

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -933.03 174.18 -343.96 -115.56 336.62

Jacobio Pharmaceuticals Group Co Net Change in Cash Calculation

Jacobio Pharmaceuticals Group Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-79.136+273.563+22.721+4.86
=222.0

Jacobio Pharmaceuticals Group Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=113.499+226.909+-4.782+0.994
=336.6

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$221.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobio Pharmaceuticals Group Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Net Change in Cash
Comparable Companies
HKSE:01873 HKSE:01541 HKSE:02179 HKSE:02509 HKSE:01521 HKSE:02616 HKSE:06660 HKSE:06978 HKSE:02487 HKSE:02181 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
77V:Germany
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Website
https://www.jacobiopharma.com
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Qiming Corporate Gp Vi, Ltd. 2201 Interest of corporation controlled by you
Qiming Venture Partners Vi, L.p. 2101 Beneficial owner
Qiming Gp Vi, L.p. 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hh Spr-iii Holdings Limited 2101 Beneficial owner
Shen Zhu 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Treasure Partner International Limited 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other

Jacobio Pharmaceuticals Group Co Headlines

No Headlines